Clinical Trial Update: Phase II Study Using Thalidomide for the Treatment of ALS [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II clinical trial evaluating thalidomide for amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 2 | Status: COMPLETED